Cardiovascular Disease Risk Factors and Metabolic Morbidity in a Longitudinal Study of Congenital Adrenal Hyperplasia.

Ahmed Torky Ninet Sinaii Smita JhaJay DesaiDiala El-Maouche Ashwini Mallappa Deborah P Merke

Published in: The Journal of clinical endocrinology and metabolism (2021)

Patients with CAH develop metabolic morbidity at a young age associated with treatment-related and familial factors. Judicious use of glucocorticoid and mineralocorticoid is warranted.

Keyphrases

cardiovascular disease
risk factors
type diabetes
early onset
middle aged
coronary artery disease
combination therapy